Abstract
In recent years, pulmonary fungal infections and invasive fungal infections (IFIs) have become increasingly prevalent due to the rising number of immunocompromised patients, such as those with Acquired Immunodeficiency Syndrome (AIDS), malignancies, or undergoing organ transplants. In this context, Histoplasma capsulatum and Cryptococcus spp. have recently been classified as fungi of high…